tert-butyl {(1S)-2-[(6-bromopyridin-3-yl)oxy]-1-methylethyl}carbamate | 1380067-94-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: tert-butyl {(1S)-2-[(6-bromopyridin-3-yl)oxy]-1-methylethyl}carbamate
• 英文别名: tert-butyl N-[(2S)-1-(6-bromopyridin-3-yl)oxypropan-2-yl]carbamate
• CAS: 1380067-94-6
• 化学式: C₁₃H₁₉BrN₂O₃
• 分子量: 331.209
• InChiKey: OOIZLIIOAANZEW-VIFPVBQESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  60.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  tert-butyl {(1S)-2-[(6-bromopyridin-3-yl)oxy]-1-methylethyl}carbamate 在 palladium diacetate 、 正丁基二(1-金刚烷基)膦 盐酸 、 potassium phosphate 作用下， 以 N-甲基吡咯烷酮 、 乙酸乙酯 为溶剂， 反应 20.0h， 生成 1-[(1S)-2-({6-[6-(cyclopropylmethoxy)-1,3-benzoxazol-2-yl]pyridin-3-yl}oxy)-1-methylethyl]-3-methylurea
  参考文献：
  名称：

  [EN] BICYCLIC COMPOUND
  [FR] COMPOSÉ BICYCLIQUE

  摘要：

  公开号：

  WO2012074126A9
• 作为产物：
  描述：

  2-溴-5-羟基吡啶 、 N-Boc-L-丙氨醇 在 bis(2-methoxyethyl) azodicarboxylate 、 三苯基膦 作用下， 以 1,4-二氧六环 为溶剂， 反应 1.0h， 以86%的产率得到tert-butyl {(1S)-2-[(6-bromopyridin-3-yl)oxy]-1-methylethyl}carbamate
  参考文献：
  名称：

  EP3059225

  摘要：

  公开号：

文献信息

• BICYCLIC COMPOUND
  申请人：YASUMA TSUNEO

  公开号：US20120142714A1

  公开（公告）日：2012-06-07

  The present invention provides a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes and the like, and having superior efficacy. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

  本发明提供了一种具有ACC抑制作用的化合物，该化合物可用作预防或治疗肥胖症、糖尿病等疾病的药物，并具有优越的功效。本发明涉及一种由式(I)表示的化合物，其中每个符号如规范中定义的，或其盐。
• Bicyclic compound
  申请人：Yasuma Tsuneo

  公开号：US08729102B2

  公开（公告）日：2014-05-20

  The present invention provides a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes and the like, and having superior efficacy. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

  本发明提供了一种具有ACC抑制作用的化合物，可用作预防或治疗肥胖症、糖尿病等药物，并具有卓越的疗效。本发明涉及一种由式（I）表示的化合物：其中每个符号如规范中所定义，或其盐。
• NOVEL ALKYLENE DERIVATIVE
  申请人：Shionogi & Co., Ltd.

  公开号：EP3059225A1

  公开（公告）日：2016-08-24

  The object of the present invention is to provide novel compounds having ACC2 inhibiting activity. In addition, the object of the present invention is to provide a pharmaceutical composition comprising the compound. A compound of formula (I): wherein R1 is substituted or unsubstituted fused aromatic heterocyclyl etc., ring A is substituted or unsubstituted non-aromatic carbocycle etc., -L1- is -O-(CR6R7)m- etc., -L2- is -O-(CR6R7)n- etc., each R6 and R7 are independently hydrogen, halogen etc., R2 is substituted or unsubstituted alkyl, R3 is hydrogen or substituted or unsubstituted alkyl, R4 is substituted or unsubstituted alkylcarbonyl etc..

  本发明的目的是提供具有 ACC2 抑制活性的新型化合物。 此外，本发明的目的是提供包含该化合物的药物组合物。 式（I）化合物：其中 R1 是取代或未取代的融合芳香杂环等，环 A 是取代或未取代的非芳香碳环等、 -L1-是-O-(CR6R7)m-等，-L2-是-O-(CR6R7)n-等，每个 R6 和 R7 独立地是氢、卤素等，R2 是取代或未取代的烷基，R3 是氢或取代或未取代的烷基，R4 是取代或未取代的烷基羰基等。
• ACC2 INHIBITORS
  申请人：Shionogi & Co., Ltd.

  公开号：EP3670496A2

  公开（公告）日：2020-06-24

  The object of the present invention is to provide novel compounds having ACC2 inhibiting activity. In addition, the object of the present invention is to provide a pharmaceutical composition comprising the compound. A compound of formula (I): wherein R1 is substituted or unsubstituted fused aromatic heterocyclyl etc., ring A is substituted or unsubstituted non-aromatic carbocycle etc., -L1- is -O-(CR6R7)m- etc., -L2- is -O-(CR6R7)n- etc., each R6 and R7 are independently hydrogen, halogen etc., R2 is substituted or unsubstituted alkyl, R3 is hydrogen or substituted or unsubstituted alkyl, R4 is substituted or unsubstituted alkylcarbonyl etc..

  本发明的目的是提供具有 ACC2 抑制活性的新型化合物。此外，本发明的目的是提供一种包含该化合物的药物组合物。 式(I)的化合物： 其中 R1 是取代或未取代的融合芳香杂环等、 环 A 是取代或未取代的非芳香族碳环等、 -L1-是-O-(CR6R7)m-等、 -L2-是-O-(CR6R7)n-等、 每个 R6 和 R7 独立地是氢、卤素等、 R2 是取代或未取代的烷基、 R3 是氢或取代或未取代的烷基、 R4 是取代或未取代的烷基羰基等。
• NOVEL ALKYLENE DERIVATIVES
  申请人：SHIONOGI & CO., LTD.

  公开号：US20160257641A1

  公开（公告）日：2016-09-08

  The object of the present invention is to provide novel compounds having ACC2 inhibiting activity. In addition, the object of the present invention is to provide a pharmaceutical composition comprising the compound. A compound of formula (I): wherein R 1 is substituted or unsubstituted fused aromatic heterocyclyl etc., ring A is substituted or unsubstituted non-aromatic carbocycle etc., -L 1 - is —O—(CR 6 R 7 )m- etc., -L 2 - is —O—(CR 6 R 7 )n- etc., each R 6 and R 7 are independently hydrogen, halogen etc., R 2 is substituted or unsubstituted alkyl, R 3 is hydrogen or substituted or unsubstituted alkyl, R 4 is substituted or unsubstituted alkylcarbonyl etc.